• $5.0M
    Market Cap
  • 1.55%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
14.2M
+3.28%
13.8M
+1.49%
13.6M
+0.51%
13.5M
+31.08%
Cost of Revenue
10.1M
+3.73%
9.7M
-0.13%
9.7M
-0.67%
9.8M
+243.53%
Gross Profit
4.2M
+2.19%
4.1M
+5.58%
3.9M
+3.59%
3.7M
+6.74%
Sales and Marketing Expense
139,238
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
0
N/A
0
-100.00%
345,095
-0.03%
345,188
-9.98%
Total Operating Expenses
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-245,461
+0.52%
-244,189
-53.88%
-529,473
+71.42%
-308,877
-49.10%
Interest Income and Expense and Net
-245,461
+0.52%
-244,189
-53.88%
-529,473
+71.42%
-308,877
-49.10%
Total Nonoperating Income and Expense
245,461
+0.52%
244,189
-53.88%
529,473
+71.42%
308,877
-49.10%
Income before Taxes
-2.5M
+92.51%
-1.3M
-81.57%
-6.9M
+71.94%
-4.0M
-15.94%
Income Taxes
N/A
N/A
0
-100.00%
33,600
-15.23%
39,637
+188.08%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-2.5M
+92.51%
-1.3M
-81.57%
-6.9M
+71.94%
-4.0M
-15.94%
Net Income from Continuing Operations Applicable to Common
-2.5M
+92.51%
-1.3M
-81.57%
-6.9M
+71.94%
-4.0M
-15.94%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted Weighted Average Shares
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
598,203
+8.28%
552,467
+122.40%
248,416
-65.25%
714,826
-32.47%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
598,203
+8.28%
552,467
+122.40%
248,416
-65.25%
714,826
-32.47%
Total Current Assets
1.7M
-1.09%
1.8M
+6.35%
1.6M
-48.64%
3.2M
+50.76%
Accumulated Depreciation
0
N/A
0
+100.00%
-805,263
-4.33%
-841,735
+122.03%
Property and Plant and Equipment and Net
142,010
-94.61%
2.6M
-8.62%
2.9M
-16.25%
3.4M
-43.24%
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
59,040
0.00%
Total Assets
6.4M
-32.95%
9.6M
-6.92%
10.3M
-38.73%
16.8M
-3.03%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
9.1M
-0.26%
9.2M
+16.38%
7.9M
+38.37%
5.7M
-16.86%
Total Long-Term Debt
1.0M
-36.72%
1.6M
+3.25%
1.6M
+354.27%
345,442
-66.06%
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
11.6M
-4.44%
12.2M
+7.61%
11.3M
+11.08%
10.2M
+2.10%
Retained Earnings
-44.5M
+6.44%
-41.8M
+3.70%
-40.3M
+20.61%
-33.4M
+13.43%
Total Stockholders Equity
-5.2M
+100.42%
-2.6M
+152.82%
-1.0M
-115.60%
6.6M
-10.00%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
1.1M
-23.66%
1.5M
+429.91%
-452,733
-78.15%
-2.1M
+836.77%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
1.5M
+2,824.72%
52,960
+107.47%
-708,878
-134.33%
2.1M
+336.80%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-2.5M
+128.99%
-1.1M
+716.10%
-134,360
-118.64%
720,688
-54.14%
Financials Ratio
Gross Margin
29.24%
-1.05%
29.55%
+4.03%
28.41%
+3.07%
27.56%
-83.41%
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-30.76%
+139.04%
-12.87%
-74.87%
-51.22%
+116.56%
-23.65%
-21.02%
Return on Equity
62.92%
-10.57%
70.36%
+128.27%
-248.88%
+330.06%
-57.87%
-17.81%
Revenue Growth
3.28%
+119.99%
1.49%
+193.53%
0.51%
-98.37%
31.08%
-99.49%
Current Ratio
0.19
-0.84%
0.19
-8.60%
0.21
-62.89%
0.56
+81.31%
Cash Ratio
0.07
+8.64%
0.06
+91.11%
0.03
-74.90%
0.13
-18.77%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow